Xencor | XNCR - Loan Capital


Xencor reported $82.12M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
Arrowhead Research USD 1.23B 687.3M Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Cytokinetics USD 247.21M 868.77M Mar/2026
GlaxoSmithKline GBP 14.01B 696M Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
MacroGenics USD 70M 256K Dec/2025
Merck USD 46.67B 77M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Xencor USD 82.12M 5.64M Mar/2026